Neurocognitive Benefits of Second-Generation Antipsychotics Versus Placebo: Insufficient Evidence Based on a Systematic Review

被引：9
|
作者：
Takeuchi, Hiroyoshi [1 ,2 ,3 ]
Thiyanavadivel, Sadhana [1 ,4 ]
Fervaha, Gagan [1 ,5 ]
Remington, Gary [1 ,2 ,5 ,6 ]
机构：
[1] Univ Toronto, Schizophrenia Div, Complex Care & Recovery Program, Ctr Addict & Mental Hlth, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[3] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan
[4] Univ Toronto, Dept Anthropol, Toronto, ON, Canada
[5] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[6] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2017年 / 37卷 / 02期
基金：
加拿大健康研究院;
关键词：
1ST-EPISODE SCHIZOPHRENIA; METAANALYSIS; OLANZAPINE; COGNITION; RISPERIDONE;
D O I：
10.1097/JCP.0000000000000662
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：274 / 276
页数：3
相关论文
共 50 条
  • [1] Second-generation antipsychotics and constipation: A review of the literature
    De Hert, M.
    Hudyana, H.
    Dockx, L.
    Bernagie, C.
    Sweers, K.
    Tack, J.
    Leucht, S.
    Peuskens, J.
    EUROPEAN PSYCHIATRY, 2011, 26 (01) : 34 - 44
  • [2] Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies
    Hirsch, Lauren
    Yang, Jaeun
    Bresee, Lauren
    Jette, Nathalie
    Patten, Scott
    Pringsheim, Tamara
    DRUG SAFETY, 2017, 40 (09) : 771 - 781
  • [3] Second-Generation Antipsychotics for the Treatment of Disruptive Behaviour Disorders in Children: A Systematic Review
    Pringsheim, Tamara
    Gorman, Daniel
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2012, 57 (12): : 722 - 727
  • [4] Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics
    Kishimoto, T.
    Agarwal, V.
    Kishi, T.
    Leucht, S.
    Kane, J. M.
    Correll, C. U.
    MOLECULAR PSYCHIATRY, 2013, 18 (01) : 53 - 66
  • [5] Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics
    T Kishimoto
    V Agarwal
    T Kishi
    S Leucht
    J M Kane
    C U Correll
    Molecular Psychiatry, 2013, 18 : 53 - 66
  • [6] Hyponatremia in Association With Second-Generation Antipsychotics: A Systematic Review of Case Reports
    Ali, Sarah Naz
    Bazzano, Lydia A.
    OCHSNER JOURNAL, 2018, 18 (03) : 230 - 235
  • [7] Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis
    Belvederi Murri M.
    Guaglianone A.
    Bugliani M.
    Calcagno P.
    Respino M.
    Serafini G.
    Innamorati M.
    Pompili M.
    Amore M.
    Drugs in R&D, 2015, 15 (1) : 45 - 62
  • [8] Old versus new: weighing the evidence between the firstand second-generation antipsychotics
    Davis, JM
    Chen, N
    EUROPEAN PSYCHIATRY, 2005, 20 (01) : 7 - 14
  • [9] Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines
    Giampaolo, Perna
    Alessandra, Alciati
    Raffaele, Balletta
    Elisa, Mingotto
    Giuseppina, Diaferia
    Paolo, Cavedini
    Maria, Nobile
    Daniela, Caldirola
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (04)
  • [10] Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome
    Skonieczna-Zydecka, Karolina
    Loniewski, Igor
    Misera, Agata
    Stachowska, Ewa
    Maciejewska, Dominika
    Marlicz, Wojciech
    Galling, Britta
    PSYCHOPHARMACOLOGY, 2019, 236 (05) : 1491 - 1512
12345